AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lipocine Inc. Director's Dealing 2015

May 18, 2015

35074_dirs_2015-05-18_ae43ae07-eae1-4bdc-8471-de678dbd91c4.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2015-05-15

Reporting Person: Mattila Jyrki (Chief Business Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct